These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 27151024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical analysis of recombinant humanized thrombopoietin for treating 25 children with severe immune thrombocytopenia].
    Zheng J, Ma JY, Su Y, Yang J, Zhang RD, Zhou X, Wu RH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):393-8. PubMed ID: 24763011
    [Abstract] [Full Text] [Related]

  • 5. [The Treatment of Newly Diagnosed Primary Immune Thrombocytopenia by Recombinant Human Thrombopoietin Combined with Glucocorticoid].
    Yuan J, Li LY, Wang ZZ, Liu XJ, Yang L, Luo JM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):832-835. PubMed ID: 35680813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy and safety of recombinant human thrombopoietin in adult patients with primary immune thrombocytopenia during the perioperative period].
    Sun HP, Hu Q, You JH, Chen QS, Wang J, Li JM, Zhao WL.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Mar 14; 40(3):191-194. PubMed ID: 30929384
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.
    Liu X, Bai Y, Wang T, Song Y, Sun F, Xia R, Zhu F, Ma J, Lu Q, Ye X, Zhan X, Li L, Guo X, Cheng S, Li Y, Guo Z, Chen Y, Qian S, Qin L, Zhang Q, Cao S, Yang R.
    Platelets; 2023 Dec 14; 34(1):2157806. PubMed ID: 36597010
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study.
    Lin J, Wang TF, Huang MJ, Huang HB, Chen PF, Zhou Y, Dai WC, Zhou L, Feng XS, Wang HL.
    BMC Pregnancy Childbirth; 2023 Nov 27; 23(1):820. PubMed ID: 38012579
    [Abstract] [Full Text] [Related]

  • 12. A multicentre double-blind, double-dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients.
    Mei H, Xu M, Yuan G, Zhu F, Guo J, Huang R, Qin J, Lv T, Qin F, Cai H, Yin P, Qin T, Hu Y.
    Br J Haematol; 2021 Dec 27; 195(5):781-789. PubMed ID: 34528239
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Efficacy of Recombinant Human Thrombopoietin and Recombinant Human Interleukin 11 for Treatment of Chemotherapy Indu-ced Thrombocytopenia in Acute Myeloid Leukaemia Patients].
    Tang G, Wang XM, Meng JX, Luan CL, Chen JF, Wu YQ, Zhang XN, He ZY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb 27; 26(1):234-238. PubMed ID: 29397850
    [Abstract] [Full Text] [Related]

  • 15. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM, Zou XY, Zhao YQ, Han SM, Shan YD, Thrombopoietin Clinical Trail Cooperation Group.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):397-400. PubMed ID: 15061993
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of recombinant human thrombopoietin combined with glucocorticoids in the treatment of immune thrombocytopenia.
    Zhou JX, Gao L, Hu N, Yan ZL, Tian CY, Su J, Qi JJ, Yue JS, Ma WT.
    Hematology; 2022 Dec 02; 27(1):1062-1068. PubMed ID: 36094428
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and safety of high-dose dexamethasone combined with rhTPO for newly diagnosed adults with severe immune thrombocytopenia].
    Li Y, Huang Q, Wang C, Muhebaier, An L, Wang X.
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb 02; 37(2):134-7. PubMed ID: 27333620
    [Abstract] [Full Text] [Related]

  • 18. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM, Xu GX, Zhao YQ, Han SM, Shan YD.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug 02; 26(4):437-41. PubMed ID: 15379272
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
    Liu Y, Jin G, Sun J, Wang X, Guo L.
    Int J Infect Dis; 2020 Sep 02; 98():144-149. PubMed ID: 32561426
    [Abstract] [Full Text] [Related]

  • 20. Effect of recombinant human thrombopoietin on immune thrombocytopenia in pregnancy in a murine model.
    Liu Y, Wang R, Han P, Zhao Y, Li G, Li G, Nie M, Wang L, Chen J, Liu X, Hou M.
    Int Immunopharmacol; 2019 Feb 02; 67():287-293. PubMed ID: 30572253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.